Zinc-induced adaptive changes in NMDA/glutamatergic and serotonergic receptors (Q43191744)

15 November 2017

title

Zinc-induced adaptive changes in NMDA/glutamatergic and serotonergic receptors (English)

1 reference

15 November 2017

2

1 reference

15 November 2017

Anna Piotrowska

6

0 references

Bernadeta Szewczyk

Bernadeta Szewczyk

7

0 references

Gabriel Nowak

Gabriel Nowak

10

0 references

Andrzej Pilc

9

Andrzej Pilc

1 reference

15 November 2017

8

Ewa Poleszak

1 reference

15 November 2017

Agata Siwek

5

0 references

Beata Legutko

3

Beata Legutko

1 reference

15 November 2017

Lucyna Pomierny-Chamioło

4

Lucyna Pomierny-Chamioło

1 reference

15 November 2017

1

Agnieszka Cichy

1 reference

15 November 2017

publication date

1 November 2009

1 reference

15 November 2017

published in

Pharmacological Reports

1 reference

15 November 2017

volume

61

1 reference

15 November 2017

issue

6

1 reference

15 November 2017

page(s)

1184-1191

1 reference

Antagonist properties of eliprodil and other NMDA receptor antagonists at rat NR1A/NR2A and NR1A/NR2B receptors expressed in Xenopus oocytes.

15 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970182-3

7 January 2021

5-HT1A and beyond: the role of serotonin and its receptors in depression and the antidepressant response

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970182-3

7 January 2021

Interaction of zinc with antidepressants in the tail suspension test

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970182-3

7 January 2021

Involvement of glutathione, ERK1/2 phosphorylation and BDNF expression in the antidepressant-like effect of zinc in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970182-3

7 January 2021

Antidepressant-like properties of zinc in rodent forced swim test

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970182-3

7 January 2021

The effects of paroxetine given repeatedly on the 5-HT receptor subpopulations in the rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970182-3

7 January 2021

Expression and characterization of a glycine-binding fragment of the N-methyl-D-aspartate receptor subunit NR1.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970182-3

7 January 2021

Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970182-3

7 January 2021

Zinc treatment induces cortical brain-derived neurotrophic factor gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970182-3

7 January 2021

Adaptation of cortical but not hippocampal NMDA receptors after chronic citalopram treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970182-3

7 January 2021

Antidepressant-like effects of acute and chronic treatment with zinc in forced swim test and olfactory bulbectomy model in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970182-3

7 January 2021

On the slowness of action of tricyclic antidepressant drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970182-3

7 January 2021

High-affinity zinc inhibition of NMDA NR1-NR2A receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970182-3

7 January 2021

Effects of imipramine on serotonergic and beta-adrenergic receptor binding in a realistic animal model of depression

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970182-3

7 January 2021

Adaptation of the NMDA receptor in rat cortex following chronic electroconvulsive shock or imipramine.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970182-3

7 January 2021

Involvement of NMDA receptors and L-arginine-nitric oxide pathway in the antidepressant-like effects of zinc in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970182-3

7 January 2021

Innovative approaches for the development of antidepressant drugs: current and future strategies

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970182-3

7 January 2021

The catecholamine hypothesis of affective disorders: a review of supporting evidence

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970182-3

7 January 2021

Zinc supplementation augments efficacy of imipramine in treatment resistant patients: a double blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970182-3

7 January 2021

Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970182-3

7 January 2021

Antidepressant-like activity of zinc: further behavioral and molecular evidence

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970182-3

7 January 2021

The involvement of serotonergic system in the antidepressant effect of zinc in the forced swim test

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970182-3

7 January 2021

Separating dual effects of zinc at recombinant N-methyl-D-aspartate receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970182-3

7 January 2021

10.1016/S1734-1140(09)70182-3

Identifiers

DOI

1 reference

15 November 2017

1 reference